Your search returned 45 results.

Results
	41.	Absence of hepatitis B and C viruses in pediatric idiopathic membranoproliferative glomerulonephritis. [electronic resource] by Nowicki, M J Welch, T R Ahmad, N Kuramoto, I K Mendoza, E C Zeldis, J B Baroudy, B M Balistreri, W F Producer: 19950612 In: Pediatric nephrology (Berlin, Germany) vol. 9 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	42.	Generation of transmissible hepatitis C virions from a molecular clone in chimpanzees. [electronic resource] by Hong, Z Beaudet-Miller, M Lanford, R E Guerra, B Wright-Minogue, J Skelton, A Baroudy, B M Reyes, G R Lau, J Y Producer: 19990504 In: Virology vol. 256 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	43.	Virus-specific cofactor requirement and chimeric hepatitis C virus/GB virus B nonstructural protein 3. [electronic resource] by Butkiewicz, N Yao, N Zhong, W Wright-Minogue, J Ingravallo, P Zhang, R Durkin, J Standring, D N Baroudy, B M Sangar, D V Lemon, S M Lau, J Y Hong, Z Producer: 20000518 In: Journal of virology vol. 74 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	44.	Piperazine-based CCR5 antagonists as HIV-1 inhibitors. II. Discovery of 1-[(2,4-dimethyl-3-pyridinyl)carbonyl]-4- methyl-4-[3(S)-methyl-4-[1(S)-[4-(trifluoromethyl)phenyl]ethyl]-1-piperazinyl]- piperidine N1-oxide (Sch-350634), an orally bioavailable, potent CCR5 antagonist. [electronic resource] by Tagat, J R Steensma, R W McCombie, S W Nazareno, D V Lin, S I Neustadt, B R Cox, K Xu, S Wojcik, L Murray, M G Vantuno, N Baroudy, B M Strizki, J M Producer: 20011204 In: Journal of medicinal chemistry vol. 44 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	45.	SCH-C (SCH 351125), an orally bioavailable, small molecule antagonist of the chemokine receptor CCR5, is a potent inhibitor of HIV-1 infection in vitro and in vivo. [electronic resource] by Strizki, J M Xu, S Wagner, N E Wojcik, L Liu, J Hou, Y Endres, M Palani, A Shapiro, S Clader, J W Greenlee, W J Tagat, J R McCombie, S Cox, K Fawzi, A B Chou, C C Pugliese-Sivo, C Davies, L Moreno, M E Ho, D D Trkola, A Stoddart, C A Moore, J P Reyes, G R Baroudy, B M Producer: 20011204 In: Proceedings of the National Academy of Sciences of the United States of America vol. 98 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)